MediXall Group, Inc.
MDXL
$0.0039
$0.000411.43%
OTC PK
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Net Income | 50.39% | 60.16% | 18.40% | 16.22% | 36.98% |
Total Depreciation and Amortization | -30.77% | -75.56% | -20.23% | 161.90% | 30.00% |
Total Amortization of Deferred Charges | -84.27% | -83.84% | -93.62% | 19.11% | 1,061.54% |
Total Other Non-Cash Items | -- | -- | -84.17% | 292.83% | 28.08% |
Change in Net Operating Assets | 35.32% | -30.92% | 872.90% | -70.63% | -45.41% |
Cash from Operations | 6.84% | 31.12% | 66.34% | 70.61% | 66.30% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -17.80% | -20.99% | -60.10% | -68.05% | -65.64% |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -100.00% | -- | -100.00% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -17.80% | -21.31% | -61.61% | -68.05% | -67.02% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -230.06% | 4,018.18% | 101.52% | 90.95% | -76.68% |